The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Will Be The Estimated Market Valuation Of The Pharmacovigilance Market By The End Of 2030?
The pharmacovigilance market has experienced swift expansion recently. Its valuation is set to climb from $9.64 billion in 2025 to $10.86 billion in 2026, driven by a compound annual growth rate (CAGR) of 12.7%. Historically, this growth has stemmed from factors such as a rise in adverse drug reaction reporting, a broader scope of global pharmaceutical approvals, an increase in clinical trial volumes, the implementation of international drug safety regulations, and greater drug usage for chronic diseases.
The pharmacovigilance market is set to experience significant expansion in the upcoming years. Its valuation is projected to reach $17.41 billion by 2030, progressing at a compound annual growth rate (CAGR) of 12.5%. This anticipated growth is influenced by factors such as the increasing utilization of real-world data, the growing number of approvals for biologics and biosimilars, the rising complexity of combination therapies, the spread of pharmacovigilance practices in emerging markets, and an enhanced focus on patient safety outcomes. Prominent trends for this period include the scaling up of post-marketing surveillance activities, the wider adoption of real-world evidence in safety monitoring, more stringent regulatory scrutiny and compliance requirements, an increase in the outsourcing of pharmacovigilance services, and the consolidation of multisource safety data platforms.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp
Which Market Drivers Are Supporting The Expansion Of The Pharmacovigilance Market?
Heightened research and development efforts are anticipated to propel the pharmacovigilance market. By allocating resources to R&D, pharmaceutical companies can formulate novel and advanced drugs with superior safety profiles. Rigorous preclinical and clinical assessments during the drug development lifecycle facilitate the early recognition of potential safety concerns, allowing for the implementation of appropriate risk mitigation strategies. Moreover, R&D endeavors advance technologies for monitoring adverse events, analyzing data, and detecting signals, thereby facilitating the swift identification of adverse drug reactions in the post-marketing stage. For instance, in 2023, according to Office for National Statistics, a UK-based, government agency, the UK government’s net spending on research and development (R&D) increased to £17.4 billion in 2023, up from £16.1 billion in 2022, marking an 8.2% rise. Consequently, the expanding research and development activities have supported the growth of the pharmacovigilance market.
Which Segment Classifications Shape The Pharmacovigilance Market?
The pharmacovigilance market covered in this report is segmented –
1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining
2) By Service Provider: In-House, Contract Outsourcing
3) By Process Flow: Case Data Management, Signal Detection, Risk Management System
4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV
5) By End User: Hospitals, Pharmaceutical Companies, Other End Users
Subsegments:
1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals
2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies
3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs
4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies
5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems
How Are Trends Impacting The Pharmacovigilance Market?
Leading entities within the pharmacovigilance market are increasingly directing their attention towards artificial intelligence (AI) as a means to enhance operational efficiency. AI possesses the capability to boost the effectiveness and precision of pharmacovigilance tasks, thereby contributing to superior patient results. Through the deployment of AI, pharmaceutical firms can optimize their workflows, refine data handling, and expedite the drug discovery process, all while simultaneously cutting expenditures and bolstering safety measures. An illustrative example occurred in August 2024, when the Government of India rolled out the Adverse Drug Reaction Monitoring System (ADRMS) software, unveiled by the Minister of Health & Family Welfare and Minister of Chemicals and Fertilizers. This specific pharmacovigilance software simplifies the gathering and examination of negative occurrences associated with medicines and medical apparatus, thereby streamlining the reporting procedure for both end-users and medical practitioners. This undertaking considerably reinforces India’s pharmacovigilance framework by guaranteeing a more thorough acquisition of safety information and elevating the oversight of drug safety. The ADRMS is designed to elevate the effectiveness of drug safety supervision and adherence to regulatory benchmarks, aiding in establishing India as a prominent player in the worldwide pharmaceutical sector.
Which Companies Are Expanding Their Footprint In The Pharmacovigilance Market?
Major companies operating in the pharmacovigilance market are IQVIA, Cognizant, ICON Plc, Accenture plc, PAREXEL International Corporation, United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Secure AI Labs, OmniSol dot Tech, Prevnos Inc., Lifescient Inc, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., Novasyte, Fortrea Holdings Inc., Syneos Health Clinical, Telerx Marketing Inc.
Read the full pharmacovigilance market report here:
https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report
How Is The Pharmacovigilance Market Distributed Across Key Geographic Regions?
North America was the largest region in the pharmacovigilance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Pharmacovigilance Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=5928&type=smp
Browse Through More Reports Similar to the Global Pharmacovigilance Market 2026, By The Business Research Company
Pharmacovigilance Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report
Medical Devices Vigilance Market Report 2026
https://www.thebusinessresearchcompany.com/report/medical-devices-vigilance-global-market-report
Cosmetovigilance Market Report 2026
https://www.thebusinessresearchcompany.com/report/cosmetovigilance-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model